Mani (7730) Stock Overview
Engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
7730 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Mani, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,691.00 |
| 52 Week High | JP¥1,955.00 |
| 52 Week Low | JP¥1,171.00 |
| Beta | 0.38 |
| 1 Month Change | -0.059% |
| 3 Month Change | 7.43% |
| 1 Year Change | 41.98% |
| 3 Year Change | 3.02% |
| 5 Year Change | -33.40% |
| Change since IPO | 1,563.28% |
Recent News & Updates
7730: Dividend Increase And Stable Assumptions Will Shape Balanced Future Upside
Analysts now see Mani's fair value at ¥1,872.14, up from ¥1,752.14, reflecting slightly adjusted assumptions for the discount rate, revenue growth, profit margin, and forward P/E multiples in their updated models. What's in the News Mani announced a cash dividend of ¥17.00 per share for the second quarter ended February 28, 2026, compared with ¥16.00 per share a year earlier (Key Developments).There May Be Reason For Hope In Mani's (TSE:7730) Disappointing Earnings
Mani, Inc.'s ( TSE:7730 ) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed...China GPO Pricing And Distribution Shifts Will Pressure Margins And Earnings
Catalysts About Mani Mani manufactures and sells medical devices across Surgical, Eyeless Needle and Dental segments, with production and distribution spanning Japan, China, Europe, Vietnam and other regions. What are the underlying business or industry changes driving this perspective?Recent updates
Shareholder Returns
| 7730 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -3.5% | -1.6% | -0.2% |
| 1Y | 42.0% | 19.7% | 42.7% |
Return vs Industry: 7730 exceeded the JP Medical Equipment industry which returned 19.7% over the past year.
Return vs Market: 7730 matched the JP Market which returned 42.7% over the past year.
Price Volatility
| 7730 volatility | |
|---|---|
| 7730 Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in JP Market | 9.3% |
| 10% least volatile stocks in JP Market | 2.4% |
Stable Share Price: 7730 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7730's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 4,140 | Masaya Watanabe | www.mani.co.jp |
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy.
Mani, Inc. Fundamentals Summary
| 7730 fundamental statistics | |
|---|---|
| Market cap | JP¥171.10b |
| Earnings (TTM) | JP¥5.60b |
| Revenue (TTM) | JP¥31.26b |
Is 7730 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7730 income statement (TTM) | |
|---|---|
| Revenue | JP¥31.26b |
| Cost of Revenue | JP¥10.72b |
| Gross Profit | JP¥20.55b |
| Other Expenses | JP¥14.95b |
| Earnings | JP¥5.60b |
Last Reported Earnings
Feb 28, 2026
Next Earnings Date
Jul 15, 2026
| Earnings per share (EPS) | 56.86 |
| Gross Margin | 65.73% |
| Net Profit Margin | 17.92% |
| Debt/Equity Ratio | 0% |
How did 7730 perform over the long term?
See historical performance and comparisonDividends
Does 7730 pay a reliable dividends?
See 7730 dividend history and benchmarks| Mani dividend dates | |
|---|---|
| Ex Dividend Date | Aug 28 2026 |
| Dividend Pay Date | Nov 05 2026 |
| Days until Ex dividend | 81 days |
| Days until Dividend pay date | 150 days |
Does 7730 pay a reliable dividends?
See 7730 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/08 07:55 |
| End of Day Share Price | 2026/06/08 00:00 |
| Earnings | 2026/02/28 |
| Annual Earnings | 2025/08/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mani, Inc. is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kazue Yanagisawa | CLSA |
| Jay Defibaugh | CLSA |
| Anna Kato | Daiwa Securities Co. Ltd. |